Outlook Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OTLK and other ETFs, options, and stocks.About OTLK
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF.
OTLK Key Statistics
Stock Snapshot
As of today, Outlook Therapeutics(OTLK) shares are valued at $1.48. The company's market cap stands at 231.42M, with a P/E ratio of -1.33.
On 2026-07-05, Outlook Therapeutics(OTLK) stock traded between a low of $1.43 and a high of $1.63. Shares are currently priced at $1.48, which is +3.5% above the low and -9.2% below the high.
Outlook Therapeutics(OTLK) shares are trading with a volume of 5.17M, against a daily average of 10.66M.
In the last year, Outlook Therapeutics(OTLK) shares hit a 52-week high of $3.39 and a 52-week low of $0.16.
In the last year, Outlook Therapeutics(OTLK) shares hit a 52-week high of $3.39 and a 52-week low of $0.16.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.